Schedule 13G ownership disclosure

Amphastar Pharmaceuticals Inc

Common Stock · CUSIP: 03209R103

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Jack Y. Zhang

    Shares: 12,524,153.00 · Class: 24.8%

  • Mary Z. Luo

    Shares: 12,524,153.00 · Class: 24.8%

  • Applied Physics & Chemistry Laboratories, Inc.

    Shares: 6,827,679.00 · Class: 14.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-010636
Form type
SCHEDULE 13G/A
Filer
Amphastar Pharmaceuticals, Inc.
CIK
CIK 1297184
Filed
Feb 07, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub